Targeting antioxidants to mitochondria by conjugation to lipophilic cations

Michael P Murphy1, Robin A J Smith

  • 1MRC Dunn Human Nutrition Unit, Wellcome Trust/MRC Building, Cambridge CB2 2XY, United Kingdom. mpm@mrc-dunn.cam.ac.uk

Insights

Mitochondria-targeted antioxidants, developed by linking a positive charge to antioxidants, accumulate within mitochondria. These compounds show promise for treating degenerative diseases by protecting mitochondria from oxidative damage after oral delivery.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cell Biology

Background:

  • Mitochondrial oxidative damage is implicated in various degenerative diseases.
  • Targeting antioxidants to mitochondria is a potential therapeutic approach.
  • Mitochondria-targeted antioxidants can be developed using lipophilic cations.

Purpose of the Study:

  • To review the development and efficacy of mitochondria-targeted antioxidants.
  • To explore their potential in treating diseases associated with mitochondrial oxidative damage.

Main Methods:

  • Conjugation of lipophilic triphenylphosphonium cation to antioxidant moieties (ubiquinol, alpha-tocopherol).
  • Assessment of compound ability to cross biological membranes, including the blood-brain barrier.
  • Evaluation of mitochondrial accumulation driven by membrane potential.
  • Testing efficacy following oral delivery in protecting mitochondria from oxidative damage.

Main Results:

  • Mitochondria-targeted antioxidants readily cross biological membranes and accumulate within mitochondria.
  • These compounds demonstrate protective effects against mitochondrial oxidative damage.
  • Oral administration leads to effective mitochondria protection.

Conclusions:

  • Mitochondria-targeted antioxidants represent a promising therapeutic strategy for degenerative diseases.
  • Their selective accumulation and protective effects offer a novel approach to mitochondria-based therapies.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...